109 related articles for article (PubMed ID: 4761687)
1. Comparative studies on the reduction of the response to the long-acting thyroid stimulator by soluble fractions from human, ovine, bovine and porcine thyroids.
Dirmikis S; Munro DS
J Endocrinol; 1973 Dec; 59(3):579-92. PubMed ID: 4761687
[No Abstract] [Full Text] [Related]
2. Studies on the interaction of long-acting thyroid stimulator (LATS) with soluble thyroid fractions.
Amino N; Miyai K; Azukizawa M; Kumahara Y
Acta Endocrinol (Copenh); 1971 Dec; 68(4):625-44. PubMed ID: 5171628
[No Abstract] [Full Text] [Related]
3. Inactivation of long-acting thyroid stimulator in vivo.
Smith BR; Munro DS
J Endocrinol; 1972 Jan; 52(1):189-96. PubMed ID: 5061150
[No Abstract] [Full Text] [Related]
4. Some factors affecting the detection of long-acting thyroid stimulator protector using the McKenzie bioassay.
Dirmikis S
J Endocrinol; 1974 Dec; 63(3):427-38. PubMed ID: 4217816
[No Abstract] [Full Text] [Related]
5. The pathogenesis of thyrotoxicosis the discovery of LATS.
Adams DD
N Z Med J; 1975 Jan; 81(531):15-7. PubMed ID: 1055308
[No Abstract] [Full Text] [Related]
6. Stimulation of the human thyroid by infusions of plasma containing LATS protector.
Adams DD; Fastier FN; Howie JB; Kennedy TH; Kilpatrick JA; Stewart RD
J Clin Endocrinol Metab; 1974 Nov; 39(5):826-32. PubMed ID: 4425101
[No Abstract] [Full Text] [Related]
7. Characterisation of long-acting thyroid stimulator gamma-G binding protein.
Smith BR
Biochim Biophys Acta; 1971 Mar; 229(3):649-62. PubMed ID: 4929149
[No Abstract] [Full Text] [Related]
8. Neutralization of the long-acting thyroid stimulator by thyroid subcellular fractions.
Berumen FO; Lobsenz IL; Utiger RD
J Lab Clin Med; 1967 Oct; 70(4):640-9. PubMed ID: 6072404
[No Abstract] [Full Text] [Related]
9. Effects of thyroglobulin on thyroid function.
Burke G; Szabo M
J Clin Endocrinol Metab; 1972 Oct; 35(4):552-60. PubMed ID: 4340789
[No Abstract] [Full Text] [Related]
10. Inhibition of long-acting thyroid stimulator by thyroid particulate fractions.
Beall GN; Solomon DH
J Clin Invest; 1966 Apr; 45(4):552-61. PubMed ID: 5937026
[No Abstract] [Full Text] [Related]
11. The thyrotrophin receptor in guinea-pig thyroid homogenate: interaction with the long-acting thyroid stimulator.
Manley SW; Bourke JR; Hawker RW
J Endocrinol; 1974 Jun; 61(3):437-45. PubMed ID: 4366120
[No Abstract] [Full Text] [Related]
12. Effects of long-acting thyroid stimulator on the reorganization into follicles of isolated thyroid cells and on the binding of radioiodinated thyrotropin to reassociated cells.
Fayet G; Verrier B; Giraud A; Lissitzky S; Pinchera A; Romaldini JH; Fenzi G
FEBS Lett; 1973 Jun; 32(2):299-302. PubMed ID: 4354817
[No Abstract] [Full Text] [Related]
13. Calmodulin purified from human and porcine thyroids inhibits thyrotropin binding to porcine thyroid cells.
Kouki T; Inui T; Hachiya T; Ochi Y; Kajita Y; Sato Y; Nagata A; Ozaki O; Ito K; Kurihara H
Thyroid; 1997 Dec; 7(6):943-8. PubMed ID: 9459642
[TBL] [Abstract][Full Text] [Related]
14. The thyroid-stimulating properties of long-acting thyroid stimulator gamma G-globulin subunits.
Smith BR; Dorrington KJ; Munro DS
Biochim Biophys Acta; 1969 Nov; 192(2):277-85. PubMed ID: 5370022
[No Abstract] [Full Text] [Related]
15. Induction of a LATS-like response by thyroglobulin in the McKenzie assay system.
Wood LC; Burger A; Peterson M; Ingbar SH
Endocrinology; 1973 May; 92(5):1538-43. PubMed ID: 4695433
[No Abstract] [Full Text] [Related]
16. The interaction of the long-acting thyroid stimulator (LATS) with thyroid tissue in vitro.
Smith BR
J Endocrinol; 1970 Jan; 46(1):45-54. PubMed ID: 5412406
[No Abstract] [Full Text] [Related]
17. Goitrogenic effect of prolonged treatment with LATS on mice immunologically tolerant to human immunoglobulin G.
Haldar J; Starr JL; Ellis M
Proc Soc Exp Biol Med; 1974 Jan; 145(1):323-30. PubMed ID: 4812866
[No Abstract] [Full Text] [Related]
18. Effect of thyrotropin releasing factor (TRF) of ovine, bovine, porcine and human origin on thyrotropin release in vitro and in vivo.
Bowers CR; Redding TW; Schally AV
Endocrinology; 1965 Oct; 77(4):609-16. PubMed ID: 5841237
[No Abstract] [Full Text] [Related]
19. Appearance of amine-containing mast cells in the mouse thyroid induced by the human long-acting thyroid stimulator (LATS).
Melander A; Sundler F
Endocrinology; 1973 May; 92(5):1362-6. PubMed ID: 4695424
[No Abstract] [Full Text] [Related]
20. Partial purification of the binding activity for the long-acting thyroid stimulator in the human thyroid.
Dirmikis S; Munro DS
J Endocrinol; 1972 Nov; 55(2):xlv-xlvi. PubMed ID: 4636369
[No Abstract] [Full Text] [Related]
[Next] [New Search]
